The Manufacturers Life Insurance Company Acquires 905 Shares of Phreesia, Inc. (NYSE:PHR)

The Manufacturers Life Insurance Company raised its holdings in shares of Phreesia, Inc. (NYSE:PHR) by 3.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,935 shares of the company’s stock after acquiring an additional 905 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Phreesia were worth $637,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Dynamic Technology Lab Private Ltd bought a new stake in Phreesia during the third quarter valued at about $549,000. Champlain Investment Partners LLC raised its holdings in Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after acquiring an additional 97,847 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Phreesia by 3.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 447,239 shares of the company’s stock valued at $10,193,000 after acquiring an additional 16,112 shares during the period. Intech Investment Management LLC bought a new stake in Phreesia during the third quarter valued at about $316,000. Finally, Quest Partners LLC raised its holdings in Phreesia by 5,361.8% during the third quarter. Quest Partners LLC now owns 31,296 shares of the company’s stock valued at $713,000 after acquiring an additional 30,723 shares during the period. 92.10% of the stock is owned by institutional investors.

Insider Buying and Selling at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 1,212 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total transaction of $25,488.36. Following the completion of the transaction, the general counsel now owns 119,791 shares in the company, valued at $2,519,204.73. The trade was a 1.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Yvonne Hui sold 2,791 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $20.92, for a total value of $58,387.72. Following the transaction, the insider now owns 27,228 shares of the company’s stock, valued at $569,609.76. This trade represents a 9.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 65,422 shares of company stock worth $1,417,561 over the last 90 days. Company insiders own 5.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Royal Bank of Canada reissued a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a report on Friday, September 27th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a report on Tuesday. Truist Financial lifted their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Tuesday. Finally, JPMorgan Chase & Co. lifted their target price on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, September 9th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and an average price target of $29.33.

Phreesia Trading Up 1.6 %

Shares of NYSE PHR opened at $24.94 on Friday. The business’s 50 day moving average is $20.45 and its two-hundred day moving average is $21.82. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The stock has a market capitalization of $1.45 billion, a P/E ratio of -16.97 and a beta of 0.98.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. During the same period in the previous year, the firm posted ($0.58) earnings per share. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. As a group, research analysts expect that Phreesia, Inc. will post -1.22 EPS for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.